Smooth Muscle Physiology Flashcards
(52 cards)
What is resting membrane potential
-40 to -70mV
contraction occurs when membrane potential is
more positive (depolarized)
*Ca rushes in
relaxation occurs when membrane potential is
more negative (hyperpolarized)
describe smooth muscle contraction
agonist binds to gq receptor which activates PLC which converts PIP2 to DAG and IP3 which causes release of Ca from the sarcoplasmic reticulum.
Also Ca rushed in through voltage gated Ca channels.
Then Ca/Calmodulin is activated which activates MLC Kinase.
MLC kinase phosphorylates MLC which causes contracteion.
Active Myosin phosphatase dephsphorylates MLC making MLC relax.
Myosin phosphatase was activated which RhA-GDP (inactive) was converted to RhoA-GTP and then dephosphorylated myosin phosphatase activating it
Mechanisms of smooth muscle contractin
- pharmacological coupling
- receptors/Intracellular signaling
- neurotransmitters, hormones, paracrine factors
Mechanisms of smooth muscle relaxation
paracrine factors
membrane potential
Therapeutic Application for smooth muscle relaxation CV Obstetrics GI Motility Pulmonary
- CV:vasodilators
- OB: uterin relaxation
- GI Motility: contraction
- Pulmonary: bronchodilators
Preload
volume of blood in the ventricles at the end of diastole (EDP)
-increase in: hypervolemia, regurgitation of cardiac valves
Afterload
Resistance left ventricle must overcome to circulate blood
- increased in hypertension, vasoconstriction
- increase in after load causes and increase in cardiac work load
Pharmacological Actions of Vasodilator drugs
- NO
- Increase or decrease cell memebrane channela ctivity
- increase smooth muscle cAMP or cGMP levels
- activate vasodilator receptors
- inhibit vasoconstrictor pathways and receptors
Nitric Oxide donors mechanism of action is via which second messengers
-cGMP and protein kinase G
Nitric oxide combines with the heme group of soluble guanylyl cyclase (sGC),
activating that enzyme and causing an increase in cGMP. An increased smooth
muscle cGMP level activates K+ channels and enhances myosin light chain (MLC)
dephosphorylation to cause relaxation.
Nitroprusside
arteriole and venule dilator
Organic Nitrates
- Nitroglycerin
- Nitroprusside
Nitroglycerin
Action: Venous Circulation (dominant) (decrease preload)
Use: Angina/ Coronary Artery Disease
Administration: Sublingual to avoid first pass effect. Reaches therapeutic levels quickly and has short duration (15-30 minutes)
Contraindication: Elevated intracranial pressure
Toxicity: Hypotension, tachycardia
Nitropruside
Action: NO releasing
Arterial and Venous circulations (decrease afterload and decrease preload)
Use: Hypertensive emergencies-rapid reduction in arterial pressure
Administration:
Intravenus
Rapid offset after discontinuing
Short duration (15-30 minutes)
Toxicity:
Hypotension, cyanide accumulation
Direct Vasodilators
Hydralazine
Minoxidil
Diazoxide
Hydralazine
Action: ***Arterial circulation (decrease afterload)
Use: Heart failure/HTN
Administration: oral for long term , combined with nitrates for heart failure
Minoxidil
Action: ***Arterial circulation decrease afterload, adn K ATP CHannel opener
Use: Heart failure/ Hypertension
Administration: oral for long-term
Toxicity: Hypertrichosis (hair growth)
Diazoxide
Action: Arterial circulation (decrease afterload)
K channel opener
Use: Hypertensive emergencies
administration:
oral-long acting
IV-rapid decrease in vascular resistance and arterial blood pressure
Toxicity: Hypotension
Ca Channel blockers
- Dihydropyridines-nifedipine, nicardipine, amplodipine
- Phenylalkylamine-Verapamil
- Benzothiazapines-dilitazem
Calcium channel blockers infor
Action: ***Arterial circulation (dominant), Vascular smooth muscle selectivity-dihydropridines are greater ration vascular versus cardiac effects.
Nimodipine has cerebral vascular selectivity
Use: HTN
Angina
Cerebral and coronary vasospasm
Phosphodiesterase Inhibitors what are the effects of the different phosphodiesterases on the vascular smooth muscle vs. the heart
VSM:
1.cGMP causes relaxation and is broken down by PDE5. So a PDE5 inhibitor would increase cGMP
- cAMP causes relaxation and is broken down by PDE3. so a PDE3 inhibitor would increase cAMP
Heart
1. Only cAMP is active. and is broken down by PDE3. SO a PDE3 inhibitor would increase cAMP which would increase contractility bc in the heart cAMP increases contractility
Wht is the differenc ebetween what cAMP does in the VSM vs in the heart
cAMP in the VSM causes relaxation and therefore vasodilation,
cAMP in the heart causes an increase in contractility
PDE3 Inhibitors
Milrinone, Inamrinone
heart
*phosphorylation of Ca Channels-inotropic
*Phosphorylates microfilaments-Inotropic
Phosphorylates K Channels and repolarizes-Chronotropic
VSM:
Inhibits myosin light chain kinase
phosphorylates K channels-hyperpolarization